 CANTON, Mass., June 30, 2022 GLOBE NEWSWIRE -- Organogenesis Holdings Inc. Nasdaq: ORGO, a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical Sports Medicine markets, today announced that second quarter of fiscal year 2022 financial results will be reported after the market closes on Tuesday, August 9th. 